Advertisement

The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions.

02:58 EDT 19th May 2013 | BioPortfolio

Summary of "The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions."

No Summary Available

Affiliation

From the Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700RB Groningen, The Netherlands.

Journal Details

This article was published in the following journal.

Name: European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology
ISSN: 1879-0844
Pages:

Links

Medical and Biotech [MESH] Definitions

Journal Impact Factor

A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.

Heart Failure

A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Cardiomegaly

Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Electronic Waste

Discarded electronic devices containing valuable and sometimes hazardous materials such as LEAD, NICKEL, CADMIUM, and MERCURY. (from http://www.epa.gov/osw/conserve/materials/ecycling/faq.htm#impact accessed 4/25/2010)

Heart Failure, Systolic

Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.

Clinical Trials [ 5590 Associated Clinical Trials listed on BioPortfolio]

“ALOFT – Aliskiren Observation of Heart Failure Treatment”: Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

This study was designed to determine if patients, who have both high blood pressure and heart failure and are currently receiving drug treatment for heart failure, have an improvement in t...

Tissue Factor Expression in Stage C Heart Failure

Monocyte tissue factor (TF) was characterized in Class C heart failure (HF) vs. 25 age-matched volunteers. TF was 2.9 fold higher (p < 0.001) in HF patients vs. controls. HF patients show...

European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

The purpose of this study is to assess the efficacy, tolerability and safety of dronedarone versus placebo in patients with symptomatic congestive heart failure (CHF) and left ventricular...

French Observatory of Acute Heart Failure

During the last decade, progress has been made in the management of heart failure. However, the changing characteristics of patients and practices in the "real world" and their impact on t...

The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure

To investigate whether the medicines eplerenone or atorvastatin have a favourable effect on diastolic heart failure. Eplerenone is a drug that has been shown to be beneficial in Chronic H...

Search BioPortfolio:
Advertisement
Advertisement